Last reviewed · How we verify

NCT03882138

Influence of Gingival Biotype on the Outcome of Open Flap Debridement

Completed NA Last updated 20 March 2019
What this trial tests

NA trial testing open flap debridement in Chronic Periodontitis in 40 participants. Completed in 28 February 2019.

Timeline
1 December 2017
Primary endpoint
28 February 2019
28 February 2019

Quick facts

Lead sponsorPostgraduate Institute of Dental Sciences Rohtak
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 December 2017
Primary completion28 February 2019
Estimated completion28 February 2019
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Who can join

Adults 25 to 55, any sex, with Chronic Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The influence of periodontal thickness has been documented in outcome of various periodontal interventions like non surgical periodontal therapy, mucogingival therapy, guided tissue regeneration (GTR), crown lengthening and implant dentistry. There is lack of study showing the influence of gingival biotype on outcome of surgical procedure. The present study is therefore undertaken to evaluate the influence of gingival biotype on the outcome of open flap debridement for treatment of chronic periodontitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of open flap debridement

Trials testing the same drug.

Other recruiting trials for Chronic Periodontitis

Currently open trials in the same condition.

Other Postgraduate Institute of Dental Sciences Rohtak trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03882138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing